Form 4: National Healthcare Corp Senior VP & CIO, Ben Anderson Flatt, Sr., Reports Acquisition of Restricted Stock and Stock Options
SEC Form 4
Ben Anderson Flatt, Sr., Senior VP & CIO of National Healthcare Corp, reports the acquisition of 1,275 shares of restricted common stock and stock options.
Summary
- On March 5, 2025, Ben Anderson Flatt, Sr., Senior VP & CIO of National Healthcare Corp (NHC), reported acquiring 1,275 shares of common stock.
- These shares were acquired through a grant of restricted shares.
- Mr. Flatt also acquired options to purchase 12,000 shares of common stock on March 5, 2025, exercisable at $94.10, expiring on March 5, 2029.
- The restricted shares vest in three equal installments: 33 1/3% on January 1, 2026, another 33 1/3% on January 1, 2027, and the final 33 1/3% on January 1, 2028.
- Following these transactions, Mr. Flatt beneficially owns 13,171.0547 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock and option grants, which is neither particularly positive nor negative.
Positives
- The grant of restricted stock and stock options to a key executive aligns his interests with those of the shareholders.
- The vesting schedule for the restricted stock encourages long-term commitment from the executive.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects standard practices for incentivizing and retaining key personnel.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock are common in the healthcare industry.
- Companies like Brookdale Senior Living and Sunrise Senior Living also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and exercise prices are generally in line with industry norms for executive compensation.
Stakeholder Impact
- The grant of equity to executives can align their interests with shareholders, potentially driving long-term value creation.
- Employees may view the equity grants as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date exercisable for option to purchase common stock |
| 03/08/2024 | Date exercisable for option to purchase common stock |
| 03/05/2025 | Date of transaction for common stock and option to purchase common stock |
| 03/06/2025 | Date of signature for the Form 4 filing |
| 01/01/2026 | First vesting date (33 1/3%) for restricted shares |
| 02/24/2026 | Date exercisable for option to purchase common stock |
| 01/01/2027 | Second vesting date (33 1/3%) for restricted shares |
| 02/18/2027 | Expiration date for option to purchase common stock |
| 01/01/2028 | Final vesting date (33 1/3%) for restricted shares |
| 03/08/2028 | Expiration date for option to purchase common stock |
| 03/05/2029 | Expiration date for option to purchase common stock |
| 02/24/2030 | Expiration date for option to purchase common stock |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.